AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

MBRX · NASDAQ · Biotechnology

Moleculin Biotech (MBRX)

Developing Annamycin with cytarabine for relapsed or refractory acute myeloid leukemia.

$0.6913

Pre-market−0.01 (−0.86%)

At close$0.6973(+7.28%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions20 holders · as of Mar 31, 2026	0.78%	152.1K shares
Insiders3 holders · as of Aug 25, 2026	18.14%	3.53M shares
Strategic holders1 holder · as of Aug 10, 2026	9.57%	1.86M shares
Otherremainder	71.51%	13.93M shares

19.48M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (19.48M in the company's Sep 3, 2026 report, 5.34M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Walter V. Klemp¹Insiderdirector, officer: CEO and President	10.63%	2.07M	13Dfiled Aug 25, 2026 ↗
CVI Investments, Inc.Strategic	9.57%	1.86M	13Gfiled Aug 10, 2026 ↗
Jonathan P. Foster²Insiderofficer: Chief Financial Officer	6.61%	1.29M	13Dfiled Aug 25, 2026 ↗
Donald H. PickerInsiderofficer: Chief Science Officer	0.89%	174,086	Form 4filed Aug 5, 2026 ↗
Sabby Management, LLCInstitution	0.39%	75,021	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.17%	32,329	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	0.07%	13,869	13Fas of Mar 31, 2026
HRT Financial LPInstitution	0.07%	13,739	13Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution	0.03%	6,072	13Fas of Mar 31, 2026
Rockefeller Capital Management L.P.Institution	0.02%	4,421	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.02%	3,409	13Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution	0.01%	1,835	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	0.00%	491	13Fas of Mar 31, 2026
Efg International AGInstitution	0.00%	434	13Fas of Mar 31, 2026
Pinnacle Wealth Planning Services, Inc.Institution	0.00%	281	13Fas of Mar 31, 2026
Newbridge Financial Services Group, Inc.Institution	0.00%	114	13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution	0.00%	43	13Fas of Mar 31, 2026
Morgan StanleyInstitution	0.00%	36	13Fas of Mar 31, 2026
Vanguard Global Advisers, LLCInstitution	0.00%	24	13Fas of Mar 31, 2026
FMR LLCInstitution	0.00%	3	13Fas of Mar 31, 2026
Caitong International Asset Management Co., LtdInstitution	0.00%	2	13Fas of Mar 31, 2026
Danske Bank A/SInstitution	0.00%	2	13Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution	0.00%	1	13Fas of Mar 31, 2026
Cva Family Office, LLCInstitution	0.00%	1	13Fas of Mar 31, 2026
Armistice Capital, LLCStrategic	—9.99% of class, as filed	—	13D/Gfiled Feb 14, 2024 ↗

Walter V. Klemp's transaction reports restate only vehicles that traded; the 2026 ownership statement (2.07M) is used instead.
Jonathan P. Foster's transaction reports restate only vehicles that traded; the 2026 ownership statement (1.29M) is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

20 holders · 152.1K shares · 7 new positions · 11 increased · 2 reduced · 4 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Sabby Management, LLC	75.0K	0.39%	+75.0Knew	May 15, 2026
Geode Capital Management, LLC	32.3K	0.17%	+17.2K	May 15, 2026
Vanguard Capital Management LLC	13.9K	0.07%	+13.9Knew	May 15, 2026
HRT Financial LP	13.7K	0.07%	+13.7Knew	May 14, 2026
Vanguard Fiduciary Trust Co	6.1K	0.03%	+6.1Knew	May 8, 2026
Rockefeller Capital Management L.P.	4.4K	0.02%	+4.2K	May 14, 2026
UBS Group AG	3.4K	0.02%	−2.5K	May 5, 2026
Tower Research Capital LLC (TRC)	1.8K	0.01%	+442	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Klemp Walter Vincl. AnnaMed, Inc.	9.90%	2.07M	13D	Aug 25, 2026 ↗
CVI Investments, Inc.	9.90%	1.86M	13G	Aug 10, 2026 ↗
Foster Jonathan P.	6.30%	1.29M	13D	Aug 25, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Aug 3, 2026	Donald H. Pickerofficer: Chief Science Officer	Purchase · 2 lots	693,332	$0.7500	713,681
Aug 3, 2026	Walter V. Klempdirector, officer: CEO and President	Purchase	533,333	$0.7500	564,340
Aug 3, 2026	Jonathan P. Fosterofficer: Chief Financial Officer	Purchase · 2 lots	1,173,332	$0.7500	1,333,390

CongressHouse and Senate disclosures

Not reported.